المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Selma Ugurel, Alexander M.M. Eggermont, Reinhardt Dummer, Elisabeth Livingstone, Lisa Zimmer, Anne Zaremba, Georgina V. Long, Caroline Robert

المساهمون: University of Zurich, Schadendorf, Dirk

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, medicine.medical_treatment, Medizin, 610 Medicine & health, Pembrolizumab, Targeted therapy, chemistry.chemical_compound, Internal medicine, medicine, Humans, 1306 Cancer Research, Immune Checkpoint Inhibitors, Melanoma, Entinostat, business.industry, 10177 Dermatology Clinic, Immune checkpoint, Clinical trial, chemistry, 2730 Oncology, Immunotherapy, Nivolumab, business, Lenvatinib, Adjuvant

وصف الملف: 906_Zaremba_A._et_al._The_concepts_of_rechallange_and_retreatment_with_immune_checkpoints_blockade_in_melanoma_patients_EJC_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af59f477caa0569ca2410181854e889Test
https://www.zora.uzh.ch/id/eprint/206131Test/

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Paul Nathan

مصطلحات موضوعية: Oncology, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Immune checkpoint inhibitors, medicine.medical_treatment, Medizin, Context (language use), Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, Tumor Microenvironment, Humans, 030212 general & internal medicine, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Tumor microenvironment, business.industry, medicine.disease, Clinical trial, 030220 oncology & carcinogenesis, Immunotherapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1ca59ce0a443693aed8c8e11018ab9Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85092193946Test

المؤلفون: Caroline Robert, Jacob Schachter, Thierry Lesimple, C. Dutriaux, Dirk Schadendorf, Monique Tan, Axel Hauschild, Georgina V. Long, R. Dummer, Eduard Gasal, Mario Santinami, Kohinoor Dasgupta, James Larkin, Mario Mandalà, Andrew M. Haydon, John M. Kirkwood, Vanna Chiarion Sileni, Laurent Mortier, Victoria Atkinson, Marta Nyakas, Ruth Plummer

المساهمون: University of Zurich

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, medicine.medical_treatment, Medizin, Administration, Oral, 2700 General Medicine, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Oximes, Medicine, 030212 general & internal medicine, Neoplasm Metastasis, Melanoma, Trametinib, Imidazoles, Follow up studies, 10177 Dermatology Clinic, General Medicine, Middle Aged, Female, Adjuvant, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, 610 Medicine & health, Pyrimidinones, Disease-Free Survival, 03 medical and health sciences, Adjuvants, Immunologic, Double-Blind Method, Internal medicine, Humans, Stage III melanoma, Protein Kinase Inhibitors, Survival analysis, Aged, Neoplasm Staging, business.industry, Dabrafenib, Survival Analysis, Clinical trial, Mutation, business, Follow-Up Studies

وصف الملف: 848_Dummer_R._et_al._Five-Year_Analysis_of_Adjuvant_Dabrafenib_plus_Trametinib_in_Stage_III_Melanoma_NEJM_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d710d2b0f671e5dafc838391b9965d4aTest
https://www.zora.uzh.ch/id/eprint/190018Test

المؤلفون: Alan J. Korman, F. Stephen Hodi, Jedd D. Wolchok, R. Humphrey, David Berman, James P. Allison, Nils Lonberg, Steven J. O'Day, Jeffrey S. Weber, Axel Hoos, Walter J. Urba, Caroline Robert

المصدر: Annals of the New York Academy of Sciences

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, Antineoplastic Agents, General Biochemistry, Genetics and Molecular Biology, History and Philosophy of Science, Internal medicine, medicine, melanoma, Animals, Humans, Adverse effect, Survival rate, immuno-oncology, cytotoxic T-lymphocyte antigen-4, Clinical Trials as Topic, business.industry, General Neuroscience, Melanoma, Antibodies, Monoclonal, Immunotherapy, Original Articles, medicine.disease, Clinical trial, Survival Rate, Treatment Outcome, monoclonal antibody, Expanded access, Immunology, business, Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e412867fff4d0b88300d38778e3135dTest
http://europepmc.org/articles/PMC3910157Test

المؤلفون: Caroline Robert, Richard F. Kefford, Jean-Jacques Grob, Axel Hauschild, Enrique Espinosa, Salvador Martin Algarra, Dirk Schadendorf, Piotr Rutkowski, Alexander M.M. Eggermont, Helen Gogas, Reinhard Dummer

المساهمون: University of Zurich, Espinosa, Enrique

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Skin Neoplasms, Genotype, medicine.medical_treatment, Medizin, Salvage therapy, 610 Medicine & health, Antineoplastic Agents, Ipilimumab, Internal medicine, medicine, 2736 Pharmacology (medical), Humans, Pharmacology (medical), Vemurafenib, Melanoma, Survival rate, Neoplasm Staging, Pharmacology, Clinical Trials as Topic, business.industry, 10177 Dermatology Clinic, Dabrafenib, General Medicine, Immunotherapy, medicine.disease, Survival Rate, Clinical trial, 3004 Pharmacology, Drug Design, Immunology, business, Algorithms, medicine.drug

وصف الملف: 569_Espinosa_E_et_al._-_Am_J_Ther_2014.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96f3d619d2431095cf9a737795be276Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84921435382Test